Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 951 to 1000 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
951\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 5 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 5) (fmo 5) (dimethylaniline oxidase 5). [source:swissprot;acc:p49326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5364.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5885.48\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09716\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
952\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative dimethylaniline monooxygenase [n-oxide forming] 6 (ec 1.14.13.8) (flavin-containing monooxygenase 6) (fmo 6) (dimethylaniline oxidase 6). [source:swissprot;acc:o60774]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
953\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4906.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5382.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09705\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
954\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i, alpha isoform (ec 2.7.1.-) (cki-alpha) (ck1). [source:swissprot;acc:p48729]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
955\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uridine kinase-like 1. [source:swissprot;acc:q9nwz5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5548.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6086.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09698\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
956\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 3 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 3) (fmo 3) (dimethylaniline oxidase 3) (fmo form 2) (fmo ii). [source:swissprot;acc:p31513]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5364.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5884.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09695\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
957\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
structure-specific recognition protein 1 (ssrp1) (recombination signal sequence recognition protein) (t160) (chromatin-specific transcription elongation factor 80 kda subunit) (fact 80 kda subunit). [source:swissprot;acc:q08945]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4483.26\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4917.77\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09692\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
958\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin-specific transcription elongation factor large subunit. [source:refseq;acc:nm\_007192]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
959\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4379.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4803.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09689\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
960\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, epsilon type (ec 2.7.1.-) (npkc-epsilon). [source:swissprot;acc:q02156]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
11773\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
10733.2\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09688\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
961\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase b precursor (ec 5.2.1.8) (ppiase) (rotamase) (cyclophilin b) (s-cyclophilin) (scylp) (cyp-s1). [source:swissprot;acc:p23284]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
962\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
udp-n-acetylglucosamine--peptide n-acetylglucosaminyltransferase 110 kda subunit (ec 2.4.1.-) (o-glcnac transferase p110 subunit). [source:swissprot;acc:o15294]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
963\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase subunit iv isoform 1, mitochondrial precursor (ec 1.9.3.1) (cox iv-1) (cytochrome c oxidase polypeptide iv). [source:swissprot;acc:p13073]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
964\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase subunit iv isoform 2, mitochondrial precursor (ec 1.9.3.1) (cox iv-2). [source:swissprot;acc:q96kj9]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
965\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, eta type (ec 2.7.1.-) (npkc-eta) (pkc-l). [source:swissprot;acc:p24723]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11773.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10733.8\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
966\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
galectin-4 (lactose-binding lectin 4) (l-36 lactose binding protein) (l36lbp) (antigen ny-co-27). [source:swissprot;acc:p56470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7817.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8575.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09686\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
967\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein 4.1 (band 4.1) (p4.1) (epb4.1) (4.1r). [source:swissprot;acc:p11171]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7813.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8569.96\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09684\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
968\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7813.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8570.11\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
969\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 1 (neuronal protein 4.1) (4.1n). [source:swissprot;acc:q9h4g0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7813.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8569.95\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
970\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 3 (4.1b) (differentially expressed in adenocarcinoma of the lung protein 1) (dal-1). [source:swissprot;acc:q9y2j2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7813.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8570.07\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
971\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 2 (generally expressed protein 4.1) (4.1g). [source:swissprot;acc:o43491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7813.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8569.97\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
972\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
45 kda calcium-binding protein precursor (cab45) (stromal cell-derived factor 4) (sdf-4). [source:swissprot;acc:q9brk5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7813.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8570.11\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
973\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7810.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8566.29\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09682\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
974\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 2 (ec 1.14.13.8) (pulmonary flavin-containing monooxygenase 2) (fmo 2) (dimethylaniline oxidase 2) (fmo 1b1). [source:swissprot;acc:q99518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5365.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5884.52\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
975\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 1 (ec 1.14.13.8) (fetal hepatic flavin-containing monooxygenase 1) (fmo 1) (dimethylaniline oxidase 1). [source:swissprot;acc:q01740]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5365.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5884.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09679\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
976\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 4 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 4) (fmo 4) (dimethylaniline oxidase 4). [source:swissprot;acc:p31512]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5365.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5884.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09675\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
977\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u3 small nucleolar ribonucleoprotein protein mpp10 (m phase phosphoprotein 10). [source:swissprot;acc:o00566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4115.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4513.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09651\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
978\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 2 (vamp-2) (synaptobrevin 2). [source:swissprot;acc:p19065]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
979\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 1 (vamp-1) (synaptobrevin 1). [source:swissprot;acc:p23763]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
980\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vesicule-associated membrane protein 4 (vamp-4). [source:swissprot;acc:o75379]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
981\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdp-diacylglycerol--inositol 3-phosphatidyltransferase (ec 2.7.8.11) (phosphatidylinositol synthase) (ptdins synthase) (pi synthase). [source:swissprot;acc:o14735]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
982\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor gtpase activating protein 1 (adp-ribosylation factor 1 gtpase activating protein) (arf1 gap) (arf1-directed gtpase- activating protein) (gap protein). [source:swissprot;acc:q8n6t3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
983\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 3 (vamp-3) (synaptobrevin 3) (cellubrevin) (ceb). [source:swissprot;acc:q15836]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
984\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6362.64\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6976.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09642\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
985\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
986\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
987\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
maguk p55 subfamily member 3 (mpp3 protein) (discs, large homolog 3). [source:swissprot;acc:q13368]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6660.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7301.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
988\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 n (ec 6.3.2.19) (ubiquitin-protein ligase n) (ubiquitin carrier protein n) (ubc13) (bendless-like ubiquitin conjugating enzyme). [source:swissprot;acc:q16781]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6229.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6829.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0963\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
989\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducing adaptor molecule 2; stam-like protein containing sh3 and itam domains 2. [source:refseq;acc:nm\_005843]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11743.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10712.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09624\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
990\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein 4 (vasa homolog). [source:swissprot;acc:q9nqi0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5147.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5641.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09584\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transformer-2 protein homolog (tra-2 alpha). [source:swissprot;acc:q13595]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6472.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7092.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09583\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
992\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative sialoglycoprotease type 2. [source:refseq;acc:nm\_022353]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5393.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5909.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09569\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
993\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6499.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7121.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
994\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin-4 induced protein 1 precursor (fig-1 protein). [source:swissprot;acc:q96rq9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5800.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09563\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
995\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [source:swissprot;acc:p50995]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5778.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6328.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09516\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
996\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
methionyl-trna formyltransferase, mitochondrial precursor (ec 2.1.2.9) (mtfmt). [source:swissprot;acc:q96dp5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5110.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5596.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09512\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
997\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 2; component of the h/aca snornp. [source:refseq;acc:nm\_017838]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5144.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5634\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0951\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
998\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor iif, alpha subunit (tfiif-alpha) (transcription initiation factor rap74). [source:swissprot;acc:p35269]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
999\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
triacylglycerol lipase, gastric precursor (ec 3.1.1.3) (gastric lipase) (gl). [source:swissprot;acc:p07098]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5680.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6220.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.095\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1000\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba304i5.1 (novel lipase) (fragment). [source:sptrembl;acc:q96lg2]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/